You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復宏漢霖:2024年淨利潤同比大增50.3%至8.205億元 連續兩年盈利彰顯發展韌性
格隆匯 03-24 19:33
復宏漢霖(2696.HK)發佈2024年度業績,於業績期內實現營業收入約人民幣57.244億元,較去年同期增長約6.1%,淨利潤達8.205億元,同比增長50.3%,淨利潤率達14.3%,同比增長41.6%。這是繼2023年首次取得全年盈利之後,公司連續第二年實現全年盈利。核心產品商業化銷售的持續擴大成爲業績盈利的重要驅動力,產品銷售收入合計約人民幣49.335億元,同比增長8.3%。此外,公司全年研發投入達到人民幣18.405億元,同比增長28.4%。截至目前,復宏漢霖已有6款產品在中國獲批上市,4款產品在國際獲批上市,觸達50多個國家和地區,廣泛覆蓋亞洲、歐洲、拉丁美洲、北美洲和大洋洲,惠及全球超75萬患者。業績期內,公司在全球範圍內完成25項上市註冊申請遞交,並獲得17項批準,覆蓋中國、美國、歐盟、加拿大、印尼等多個國家和地區,加速產品全球化進程。同時,公司秉持差異化的創新研發策略,構建了約50個分子的多元化管線,覆蓋單抗、多抗、抗體偶聯藥物(ADC)、融合蛋白等豐富的藥物形式,並持續深化AI等前沿技術和平臺賦能,破解臨牀之需並促進創新成果轉化落地。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account